👀 Ones to watch: The MOST undervalued stocks to buy right nowSee Undervalued Stocks

Veeva Systems executive Thomas Schwenger sells shares for $270,251

Published 11/12/2024, 11:56 PM
VEEV
-

Thomas D. Schwenger, President and Chief Customer Officer at Veeva Systems Inc. (NYSE:VEEV), recently sold 1,126 shares of the company's Class A common stock. The shares were sold at a weighted average price of approximately $240.01 each, amounting to a total transaction value of $270,251. Following this sale, Schwenger retains ownership of 27,013 shares in the company.

The transaction was executed as part of a pre-arranged trading plan under Rule 10b5-1, which Schwenger had adopted on October 2, 2023. This rule allows company insiders to set up a trading plan for selling stocks they own by establishing a predetermined schedule, thus helping to avoid potential conflicts of interest.

The shares were sold in multiple transactions, with prices ranging from $240.00 to $240.095 per share. Schwenger has committed to providing detailed information about the number of shares sold at each price upon request.

Veeva Systems, based in Pleasanton, California, is a prominent provider of cloud-based software solutions for the global life sciences industry.

In other recent news, Veeva Systems has been the subject of several analyst upgrades and strategic developments. Investment firm Piper Sandler upgraded Veeva's stock target to $280 from $230, maintaining an Overweight rating, following the company's announcement of a $6 billion revenue goal for 2030. Analyst firms Oppenheimer, Baird, and Barclays (LON:BARC) also provided assessments, with Oppenheimer and Baird maintaining an Outperform rating, and Barclays reiterating an Overweight rating.

In terms of financial performance, Veeva Systems reported a 15% year-over-year increase in total revenue, totaling $676.2 million, and an earnings per share of $1.62. The company also announced a strategic partnership with Walgreens, aiming to enhance patient outcomes through the use of Veeva's Data Cloud products and services.

Veeva Systems welcomed Brian Van Wagener as their new Chief Financial Officer and expanded its clinical trial platform, Veeva Site Connect. The company also anticipates wider adoption of its Compass and EDC products in the long term. These are among the recent developments concerning Veeva Systems.

InvestingPro Insights

As Thomas D. Schwenger reduces his stake in Veeva Systems Inc. (NYSE:VEEV), recent data from InvestingPro sheds light on the company's financial position and market performance. Veeva's stock has shown significant momentum, with a 27.75% price return over the past three months and an impressive 43.49% return over the last year. This strong performance has pushed the stock to trade near its 52-week high, with the current price at 97.81% of that peak.

InvestingPro Tips highlight that Veeva holds more cash than debt on its balance sheet, indicating a solid financial foundation. This aligns with the company's position as a leading cloud-based software provider in the life sciences industry. Additionally, Veeva's liquid assets exceed its short-term obligations, further underscoring its financial stability.

However, investors should note that the stock is trading at a high earnings multiple, with a P/E ratio of 62. This valuation metric suggests that the market has high growth expectations for Veeva, which is reflected in its revenue growth of 15.29% over the last twelve months.

For those interested in a deeper analysis, InvestingPro offers 15 additional tips for Veeva Systems, providing a comprehensive view of the company's financial health and market position.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.